Drug Discovery

Our eBook features drug development stories, a drive for novel excipients, new technologies, and more.

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.

Enveda Biosciences Founder Viswa Colluru shares the lessons he has learned whilst charting the vast terra incognita of nature’s chemical structure

Work by an international team in Japan has found a new and effective way to attack cancer inside the body.

Find out how nanotechnology can overcome challenges in drug delivery to the eye.

We talk to Roche’s Paulo Fontoura about Evrysdi and its impact on patient lives.

We sit down to interview Louise Modis, Chief Scientific Officer at Mogrify, UK, about her career and role at the company.

How work on sharks could provide a highly effective weapon against new COVID variants

How will the pharmaceutical landscape shape up in 2022? Industry experts share their predictions.

COVID-19 caused a shift in scientific research. But what happened to the research programs that existed before the pandemic hit?